|
In the
Protein Scale-Up & Manufacturing meeting, experts from
around the world will share the details of reaching higher
throughput protein production. From overcoming protein
challenges to large-scale manufacturing, the protein pioneers
will describe the steps they have taken to reach success.
Their insights will provide the necessary framework for
achieving rapidly scaled up protein manufacturing.
Whether your group is getting a protein-based product ready to
go into the clinic or onto the market, the wealth of expertise
and advice gleaned from the Protein Scale-Up &
Manufacturing meeting will help you attain your goals. By
attending the meeting you will learn how leaders in the field
are efficiently scaling up production and setting new bounds.
-
Learn about the recent technologies and improved methods
-
Find out which designs and
protocols are showing the best results
-
Stay in touch with the trends and breakthroughs
-
Share information about what is needed to achieve results
Overcoming
Protein Challenges
Keynote
Presentation
Amyloid Structure in Bacterial Inclusion Bodies
Salvador Ventura, Ph.D., Associate Professor, Institute of
Biotechnology, University of Barcelona |
Endotoxin Removal in Antibody
Downstream Processing -A Novel Scaleable Process
Stefan Schmidt, Ph.D., Team Leader, Protein Science,
AstraZeneca ABL
Regulatory
Impacts—Tech Transfer
Technology Transfer to
Manufacturing: The Key to Successful Commercialization
Stephen M. Perry, President, Kymanox Inc.
Analytical Challenges to
Establishing Comparability for Biologics: Raising the
Regulatory Bar
Asenath Rasmussen, Ph.D., Associate Research Fellow,
Analytical Research & Development, Pfizer Worldwide
Pharmaceutical Sciences
Protein
Analytics
Stability of Monoclonal Antibodies
in Liquid Formulations
Ivan Correia, Ph.D., Research Investigator, Protein
Analytics, Abbott Bioresearch Center
Development, Manufacture and
Pre-Clinical Evaluation and Efficacy Studies of a Melanin
Binding IgM Antibody Labeled with 188Re Against
Experimental Human Metastatic Melanoma
in Nude Mice
Muctarr Sesay, Ph.D., Senior Director, Process Development,
Goodwin Biotechnology Inc.
Protein
Processes
PAT and Smart Chemometrics for
Assured Pharma Development and Production
Julian Morris, Ph.D., Professor, Process Control, and
Director, Centre for Process Analytics & Control
Technology, Foresight Centre CPACT, Newcastle University
Scaling
Up
From Development to Large-Scale
Manufacturing of Immunoglobulins from Human Plasma
Wolfgang Teschner, Ph.D., Director, Research, Plasma
Product Development / Product Support Global Pre-clinical
R&D, Baxter Innovations GmbH
Antibody Manufacture Pipelines -
Optimized for Speed & Quality
Ralf Ostendorp, Ph.D., Senior Director R&D, Head of
Protein Sciences, MorphoSys AG
Protein
Manufacturing
Assessing the Strategic Value of
Fast, Flexible Clinical Manufacturing Capacity
Geoffrey Hodge, Ph.D., Vice President, Process Development
& Technology, Xcellerex LLC
BioSMB:
A New Continuous, Disposable Chromatography Process
Thomas
Ransohoff, Consultant, Tarpon Biosystems Inc. & Vice
President and Senior Consultant, BioProcess Technology
Consultants Inc.
For more information, please contact:
Mary Ruberry
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
E-mail: mruberry@healthtech.com
For sponsorship and
exhibit information, contact:
Carol Dinerstein
Cambridge Healthtech Institute
Phone: 781-972-5471
E-mail: dinerstein@healthtech.com
|
